ALGID Fundamental Analysis - EGIDE

Fundamental Rating

Taking everything into account, ALGID scores 2 out of 10 in our fundamental rating. ALGID was compared to 52 industry peers in the Electronic Equipment, Instruments & Components industry. ALGID may be in some trouble as it scores bad on both profitability and health. ALGID does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALGID had negative earnings in the past year.
ALGID had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ALGID reported negative net income in multiple years.
In multiple years ALGID reported negative operating cash flow during the last 5 years.

1.2 Ratios

ALGID has a worse Return On Assets (-14.07%) than 84.62% of its industry peers.
ALGID's Return On Equity of -64.06% is on the low side compared to the rest of the industry. ALGID is outperformed by 86.54% of its industry peers.

		Industry Rank	Sector Rank
ROA	-14.07%
ROE	-64.06%
ROIC	N/A

ROA(3y)-13.63%

ROA(5y)-7.33%

ROE(3y)-55.38%

ROE(5y)-31.02%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALGID's Gross Margin of 62.91% is amongst the best of the industry. ALGID outperforms 80.77% of its industry peers.
In the last couple of years the Gross Margin of ALGID has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for ALGID so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	62.91%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.15%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALGID does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALGID has more shares outstanding
ALGID has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.63, we must say that ALGID is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ALGID (1.63) is worse than 71.15% of its industry peers.
ALGID has a debt to FCF ratio of 14.31. This is a negative value and a sign of low solvency as ALGID would need 14.31 years to pay back of all of its debts.
ALGID has a worse Debt to FCF ratio (14.31) than 67.31% of its industry peers.
ALGID has a Debt/Equity ratio of 0.98. This is a neutral value indicating ALGID is somewhat dependend on debt financing.
ALGID has a worse Debt to Equity ratio (0.98) than 82.69% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.98
Debt/FCF	14.31
Altman-Z	1.63

ROIC/WACCN/A

WACC7.27%

2.3 Liquidity

A Current Ratio of 1.57 indicates that ALGID should not have too much problems paying its short term obligations.
With a Current ratio value of 1.57, ALGID perfoms like the industry average, outperforming 44.23% of the companies in the same industry.
A Quick Ratio of 0.85 indicates that ALGID may have some problems paying its short term obligations.
ALGID's Quick ratio of 0.85 is on the low side compared to the rest of the industry. ALGID is outperformed by 67.31% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.57
Quick Ratio	0.85

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALGID shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.41%, which is quite impressive.
ALGID shows a decrease in Revenue. In the last year, the revenue decreased by -8.50%.
Measured over the past years, ALGID shows a very strong growth in Revenue. The Revenue has been growing by 28.35% on average per year.

EPS 1Y (TTM)24.41%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-16.95%

Revenue 1Y (TTM)-8.5%

Revenue growth 3Y28.35%

Revenue growth 5YN/A

Sales Q2Q%0.97%

3.2 Future

ALGID is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -25.99% yearly.
ALGID is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.68% yearly.

EPS Next Y-41.48%

EPS Next 2Y-51.41%

EPS Next 3Y-25.99%

EPS Next 5YN/A

Revenue Next Year22.46%

Revenue Next 2Y-1.63%

Revenue Next 3Y0.68%

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ALGID reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ALGID is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

The rest of the industry has a similar Price/Free Cash Flow ratio as ALGID.

		Industry Rank	Sector Rank
P/FCF	36.86
EV/EBITDA	N/A

4.3 Compensation for Growth

A cheap valuation may be justified as ALGID's earnings are expected to decrease with -25.99% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-51.41%

EPS Next 3Y-25.99%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALGID!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

EGIDE

EPA:ALGID (1/20/2026, 7:00:00 PM)

1.045

-0.03 (-2.34%)

Chartmill FA Rating

GICS SectorInformation Technology

GICS IndustryGroupTechnology Hardware & Equipment

GICS IndustryElectronic Equipment, Instruments & Components

Earnings (Last)10-20 2025-10-20

Earnings (Next)04-27 2026-04-27

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap20.49M

Revenue(TTM)30.16M

Net Income(TTM)-3.01M

Analysts86.67

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.68
P/FCF	36.86
P/OCF	24.17
P/B	4.36
P/tB	4.36
EV/EBITDA	N/A

EPS(TTM)-0.15

EYN/A

EPS(NY)-0.02

Fwd EYN/A

FCF(TTM)0.03

FCFY2.71%

OCF(TTM)0.04

OCFY4.14%

SpS1.54

BVpS0.24

TBVpS0.24

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-14.07%
ROE	-64.06%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	62.91%
FCFM	1.84%

ROA(3y)-13.63%

ROA(5y)-7.33%

ROE(3y)-55.38%

ROE(5y)-31.02%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.15%

GM growth 5YN/A

F-Score7

Asset Turnover1.41

Health

		Industry Rank	Sector Rank
Debt/Equity	0.98
Debt/FCF	14.31
Debt/EBITDA	N/A
Cap/Depr	15.76%
Cap/Sales	0.97%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.57
Quick Ratio	0.85
Altman-Z	1.63

F-Score7

WACC7.27%

ROIC/WACCN/A

Cap/Depr(3y)34.7%

Cap/Depr(5y)225.04%

Cap/Sales(3y)2%

Cap/Sales(5y)3.91%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)24.41%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-16.95%

EPS Next Y-41.48%

EPS Next 2Y-51.41%

EPS Next 3Y-25.99%

EPS Next 5YN/A

Revenue 1Y (TTM)-8.5%

Revenue growth 3Y28.35%

Revenue growth 5YN/A

Sales Q2Q%0.97%

Revenue Next Year22.46%

Revenue Next 2Y-1.63%

Revenue Next 3Y0.68%

Revenue Next 5YN/A

EBIT growth 1Y42.95%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y122.69%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y140.97%

OCF growth 3YN/A

OCF growth 5YN/A

EGIDE / ALGID.PA FAQ

Can you provide the ChartMill fundamental rating for EGIDE?

ChartMill assigns a fundamental rating of 2 / 10 to ALGID.PA.

What is the valuation status of EGIDE (ALGID.PA) stock?

ChartMill assigns a valuation rating of 1 / 10 to EGIDE (ALGID.PA). This can be considered as Overvalued.

How profitable is EGIDE (ALGID.PA) stock?

EGIDE (ALGID.PA) has a profitability rating of 2 / 10.

EGIDE (ALGID.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

EGIDE / ALGID.PA FAQ

Can you provide the ChartMill fundamental rating for EGIDE?

What is the valuation status of EGIDE (ALGID.PA) stock?

How profitable is EGIDE (ALGID.PA) stock?